| known also as: |
FREAC3), Forkhead-Related Protein FKHL7, Forkhead-Related Transcription Factor 3, Anti-FOXC1 (Forkhead Box C1 |
| known also as: |
FREAC3), Forkhead-Related Protein FKHL7, Forkhead-Related Transcription Factor 3, FOXC1 (Forkhead Box C1 |
| known also as: |
FREAC3), Forkhead-Related Protein FKHL7, Forkhead-Related Transcription Factor 3, FOXC1 (Forkhead Box C1 |
| known also as: |
FOXC1 |
| known also as: |
FREAC3), Forkhead-Related Protein FKHL7, Forkhead-Related Transcription Factor 3, Anti -FOXC1 (Forkhead Box C1 |
| Other names: |
Forkhead box protein C1, Forkhead-related protein FKHL7, Forkhead-related transcription factor 3, OTTHUMP00000017802, drosophila, forkhead, forkhead box C1, forkhead box protein C1, forkhead-related activator 3, forkhead-related protein FKHL7, forkhead-related transcription factor 3, forkhead/winged helix-like transcription factor 7, homolog-like 7, myeloid factor-delta, forkhead box protein C1 |
| Other gene names: |
ARA, FKHL7, FKHL7, FOXC1, FREAC-3, FREAC3, FREAC3, IGDA, IHG1, IRID1, RIEG3, FOXC1 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Immunoglobulin isotype: |
IgG |
| Clone: |
Polyclonal antibody |
| Host organism: |
Source: Human, Host: Rabbit |
| Species reactivity: |
Rodent, Human |
| Specificity and cross-reactivity: |
Species Crossreactivity: rodent, Recognizes human FOXC1 |
| Purification method: |
Affinity Purified by affinity chromatography |
| Form/Appearance: |
40% glycerol, sodium azide, Supplied as a liquid in PBS |
| Storage and shipping: |
Aliquots are stable for at least 12 months productone should be stored at -20 degrees Celsius, For long-term storage, For maximum recovery of product, For optimal long term storage, Further dilutions can be made in assay buffer, centrifuge the original vial after thawing and prior to removing the cap, productone should be kept at -20 degrees Celsius, Store at 4 degrees Celsius for short term storage |
| Tested for:: |
Western Blot (WB), ELISA (EL/EIA) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
C, C for long term storage and for short term at + 5°, If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24° |
| Gene target: |
FREAC3), Forkhead-Related Protein FKHL7, Forkhead-Related Transcription Factor 3, FOXC1 (Forkhead Box C1 |
| Short name: |
FREAC3) Antibody, Forkhead- Protein FKHL7, Forkhead- Transcription Factor 3, FOXC1 (Forkhead Box C1 |
| Technique: |
antibodies against human proteins, antibodies for, Antibody |
| Alternative name: |
FREAC3) (Antibody to), Forkhead-Related Protein FKHL7, Forkhead-Related Transcription Factor 3, forkhead box C1 (Forkhead Box C1 |
| Alternative technique: |
antibodies |
| Alternative to gene target: |
ARA and FKHL7 and FREAC-3 and FREAC3 and IGDA and IHG1 and IRID1 and RIEG3, DNA binding, DNA-templated and biological process this GO :0006366 and transcription from RNA polymerase II promoter and biological process this GO :0007219 and Notch signaling pathway and biological process this GO :0007420 and brain development and biological process this GO :0007507 and heart development and biological process this GO :0008134 and transcription factor binding and molecular function this GO :0008301 and DNA binding, DNA-templated and biological process this GO :0045930 and negative regulation of mitotic cell cycle and biological process this GO :0045944 and positive regulation of transcription from RNA polymerase II promoter and biological process this GO :0046620 and regulation of organ growth and biological process this GO :0048010 and vascular endothelial growth factor receptor signaling pathway and biological process this GO :0048341 and paraxial mesoderm formation and biological process this GO :0048762 and mesenchymal cell differentiation and biological process this GO :0048844 and artery morphogenesis and biological process this GO :0050880 and regulation of blood vessel size and biological process this GO :0055010 and ventricular cardiac muscle tissue morphogenesis and biological process this GO :0060038 and cardiac muscle cell proliferation and biological process this GO :1902257 and negative regulation of apoptotic process involved in outflow tract morphogenesis and biological process, FOXC1 and IDBG-56045 and ENSG00000054598 and 2296, Foxc1 and IDBG-142256 and ENSMUSG00000050295 and 17300, bending, bending and also this GO :0043565 : sequence-specific DNA binding and also this GO :0044212 : transcription regulatory region DNA binding, bending and molecular function this GO :0008354 and germ cell migration and biological process this GO :0014032 and neural crest cell development and biological process this GO :0030199 and collagen fibril organization and biological process this GO :0030203 and glycosaminoglycan metabolic process and biological process this GO :0032808 and lacrimal gland development and biological process this GO :0035050 and embryonic heart tube development and biological process this GO :0042475 and odontogenesis of dentin-containing tooth and biological process this GO :0043010 and camera-type eye development and biological process this GO :0043565 and sequence-specific DNA binding and molecular function this GO :0044212 and transcription regulatory region DNA binding and molecular function this GO :0045893 and positive regulation of transcription, nuclei, this GO :0000977 and RNA polymerase II regulatory region sequence-specific DNA binding and molecular function this GO :0001228 and RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and molecular function this GO :0001501 and skeletal system development and biological process this GO :0001503 and ossification and biological process this GO :0001541 and ovarian follicle development and biological process this GO :0001568 and blood vessel development and biological process this GO :0001654 and eye development and biological process this GO :0001657 and ureteric bud development and biological process this GO :0001701 and in utero embryonic development and biological process this GO :0001756 and somitogenesis and biological process this GO :0001822 and kidney development and biological process this GO :0001945 and lymph vessel development and biological process this GO :0001974 and blood vessel remodeling and biological process this GO :0003007 and heart morphogenesis and biological process this GO :0003677 and DNA binding and molecular function this GO :0003700 and sequence-specific DNA binding transcription factor activity and molecular function this GO :0003705 and RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005634 and nucleus and cellular component this GO :0005720 and nuclear heterochromatin and cellular component this GO :0005737 and cytoplasm and cellular component this GO :0006355 and regulation of transcription, this GO :0000977 : RNA polymerase II regulatory region sequence-specific DNA binding, this GO :0000977 : RNA polymerase II regulatory region sequence-specific DNA binding and also this GO :0001228 : RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription and also this GO :0003677 : DNA binding and also this GO :0003700 : sequence-specific DNA binding transcription factor activity and also this GO :0003705 : RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity and also this GO :0005515 : protein binding and also this GO :0008134 : transcription factor binding and also this GO :0008301 : DNA binding, this GO :0001228 : RNA polymerase II transcription regulatory region sequence-specific DNA binding transcription factor activity involved in positive regulation of transcription, this GO :0003677 : DNA binding, this GO :0003700 : sequence-specific DNA binding transcription factor activity, this GO :0003705 : RNA polymerase II distal enhancer sequence-specific DNA binding transcription factor activity, this GO :0005515 : protein binding, this GO :0008134 : transcription factor binding, this GO :0008301 : DNA binding, this GO :0043565 : sequence-specific DNA binding, this GO :0044212 : transcription regulatory region DNA binding, forkhead box C1 |
| Identity: |
3800 |
| Gene: |
FOXC1 |
More about : FOXC1 |
| Long gene name: |
forkhead box C1 |
| Synonyms gene: |
FKHL7 IRID1 |
| Synonyms: |
FREAC3 ARA IGDA IHG1 |
| Locus: |
6p25, 3 |
| Discovery year: |
1995-06-05 |
| GenBank acession: |
AF048693 |
| Entrez gene record: |
2296 |
| Pubmed identfication: |
7957066 9620769 |
| Classification: |
Forkhead boxes |
| Havana BLAST/BLAT: |
OTTHUMG00000016182 |